Company intelligence / Profile preview

Bioelectronica Jiag

Reno, Nevada, United Statesnature.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Bioelectronica has developed and commercialized the Hypercell® high-throughput single-cell sorting system and AbFinderAI platform. These technologies enable rapid, automated antibody discovery from single B cells. The company has formed strategic partnerships with major industry players such as GenScript to integrate its technology into global biopharma R&D workflows. No clinical trial results are reported since the company provides research tools rather than therapeutics directly.

Modalities: AntibodyBiologic
Industry: Drug Discovery Services

Partnerships

GenScript Biotech CorporationPharmiGENE in Taiwan

Beyond the preview

Go deeper on Bioelectronica Jiag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioelectronica Jiag.

Explore the full profile